These compounds may interact with:

Coagulation factor XI

Potentially involved in: factor xi deficiency; vascular disease; carcinoma; thrombophlebitis; crohn's disease; von willebrand's disease; thrombophilia; factor xii deficiency; hemophilia b; cerebrovascular disease; hemorrhagic disease; factor vii deficiency; alcohol-related birth defect; prothrombin deficiency; congenital afibrinogenemia; hypertensive disease; partial thromboplastin time increased (finding); bleeding tendency; autosomal recessive predisposition; factor 11 deficiency

Disease data sourced from Pharos.